Cohu CEO Luis Muller Sells Shares for $3.3 Million

Cohu CEO Luis A. Muller sold 55,794 shares at a weighted-average $60.00 per share, realizing approximately $3.3 million under a Rule 10b5-1 plan adopted May 28, 2026. The sale represented 6% of his pre-sale direct stake, leaving 871,825 shares held directly, including 508,101 unvested RSUs. Cohu shares had risen 169% over the preceding 12 months; the company reported $522.6 million in TTM revenue and a $38.8 million net loss, although revenue grew 33% year over year and its operating loss narrowed to $36 million from $70 million.

Analysis

The sale is not a standalone bearish signal, but it removes a potentially useful governance support point after a momentum-driven rerating. A 10b5-1 plan reduces informational content only if it was adopted before management possessed a material change in demand visibility; the relatively recent plan date warrants review of subsequent order, utilization, and customer commentary rather than blanket dismissal. With a large unvested-RSU component in remaining ownership, headline ownership materially overstates immediately at-risk capital.

COHU’s equity case is now more sensitive to converting semiconductor-test recovery expectations into operating leverage than to another revenue-growth print. At a premium forward earnings multiple despite current GAAP losses, even modest gross-margin or utilization misses can drive multiple compression: test-equipment demand is exposed to outsourced assembly/test spending, automotive/industrial semiconductor inventory normalization, and China-related customer capex. The relevant 1-3 month catalysts are quarterly bookings, book-to-bill, backlog conversion, and margin guidance; the 6-18 month upside requires sustained content gains in more complex test and a clean return to profitability.

Consensus may be underweighting the asymmetry of a small-cap equipment name after a sharp run: improving fundamentals can be real while the stock still de-rates if the recovery merely meets expectations. Conversely, treating this sale as a short catalyst is weak—the transaction is too small and prearranged. The actionable question is whether orders and gross margin validate the valuation, not the executive’s liquidity decision.

Key Decisions for Investors

• No directional trade solely on the Form 4; treat it as a governance watch item, not a signal to short COHU.
• For existing COHU longs, reduce tactical exposure into the next earnings report or hedge with a 1-3 month put spread if the position has appreciated materially; reassess on bookings, book-to-bill, and gross-margin guidance. Thesis is falsified by a guidance cut or evidence that backlog conversion is slipping.
• Initiate a COHU long only after confirmation of positive operating leverage—specifically, improved gross-margin guidance alongside sustained order momentum—rather than chasing momentum at a premium earnings multiple. Target a 6-12 month holding period; risk is a semiconductor test-capex pause causing a disproportionate valuation reset.
• Relative-value watch: if COHU materially underperforms diversified test peers following a clean order/margin update, consider long COHU versus short TER as a recovery-beta pair. Do not execute until peer valuation, geographic exposure, and end-market mix confirm that the spread is driven by execution rather than different cycle exposure.